INS and type 2 diabetes mellitus: Despite the poor outcomes with standard treatments and the evidence suggesting that the pathophysiology of T2DM in youth is particularly aggressive, metformin and insulin were the only FDA-approved treatments for youth with T2DM in the U.S. until recently (4–7).